MSRA-CSGALNACT1 Fusion FISH Probe
The MSRA-CSGALNACT1 Fusion FISH Probe is used to confirm a fusion of the MSRA and CSGALNACT1 genes. The fusion of the MSRA and CSGALNACT1 genes has been associated with Skin Cutaneous Melanoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| MSRA-CSGALNACT1-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| MSRA-CSGALNACT1-20-RERE | 20 (40 μL) | 200 μL |
|
|
| MSRA-CSGALNACT1-20-REOR | 20 (40 μL) | 200 μL |
|
|
| MSRA-CSGALNACT1-20-REGO | 20 (40 μL) | 200 μL |
|
|
| MSRA-CSGALNACT1-20-REGR | 20 (40 μL) | 200 μL |
|
|
| MSRA-CSGALNACT1-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| MSRA-CSGALNACT1-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| MSRA-CSGALNACT1-20-OROR | 20 (40 μL) | 200 μL |
|
|
| MSRA-CSGALNACT1-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| MSRA-CSGALNACT1-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| MSRA-CSGALNACT1-20-GORE | 20 (40 μL) | 200 μL |
|
|
| MSRA-CSGALNACT1-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| MSRA-CSGALNACT1-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| MSRA-CSGALNACT1-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| MSRA-CSGALNACT1-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| MSRA-CSGALNACT1-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| MSRA-CSGALNACT1-20-GROR | 20 (40 μL) | 200 μL |
|
|
| MSRA-CSGALNACT1-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| MSRA-CSGALNACT1-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| MSRA-CSGALNACT1-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| MSRA-CSGALNACT1-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| MSRA-CSGALNACT1-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| MSRA-CSGALNACT1-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| MSRA-CSGALNACT1-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| MSRA-CSGALNACT1-20-AQAQ | 20 (40 μL) | 200 μL |
|
MSRA Gene Summary
This gene encodes a ubiquitous and highly conserved protein that carries out the enzymatic reduction of methionine sulfoxide to methionine. Human and animal studies have shown the highest levels of expression in kidney and nervous tissue. The protein functions in the repair of oxidatively damaged proteins to restore biological activity. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]
Gene Name: Methionine Sulfoxide Reductase A
Chromosome: CHR8: 9911829 -10286401
Locus: 8p23.1
CSGALNACT1 Gene Summary
This gene encodes an enzyme that transfers N-acetylglucosamine (GalNAc) to the core tetrasaccharide linker and to elongating chondroitin sulfate chains in proteoglycans. Knockout of the orthologous mouse gene indicates that the protein is necessary for normal cartilage development and aggrecan metabolism. Mutations in this gene are associated with multiple sclerosis progression, and with mild skeletal dysplasia and joint laxity. [provided by RefSeq, Aug 2017]
Gene Name: Chondroitin Sulfate N-acetylgalactosaminyltransferase 1
Chromosome: CHR8: 19261671 -19540261
Locus: 8p21.3
Gene Diseases
The MSRA CSGALNACT1 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Skin Cutaneous Melanoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|